Monday, 6 March 2017

3D culture technology among biomedical end users

Organ on the chip & the 3D cell culture technology has been prominent as fulfilling ways to ease the price and inefficiency of the drug medicine development process. Wide range of technology in this era has been introduced; however, what comprises an 'ideal' 3D culture model has not been defined and translation has proven hard way of ease.

News published in Future Science OA from Shery Huang and colleagues at the University of Cambridge (UK) has attempted to address this problem by analyzing the ideal qualities of this technology from the point of view of the end users, the biomedical community.
"All the way a plethora of microfluidics-based culture models has been developed, the adaptation of these models to address biologically concerned research questions is sparse," noted the authors.

The group designed a survey to assess acceptance of microfluidics based 3D cell culture systems. Their final results demonstrated a positive behavior to the technology, although a gap remains between what is desired and what is available sold. In particular, the biomedical community required systems balancing complexity, user-friendliness, physiological relevance and controllability.


Post a Comment